Chronic HBV Infection

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

GS
Gilead SciencesFOSTER CITY, CA
1 program
1
GS-4774Phase 21 trial
Active Trials
NCT01943799Completed178Est. Mar 2015
Precision BioSciences
1 program
PBGENE-HBVN/A1 trial
Active Trials
NCT07254208Not Yet Recruiting45Est. Jun 2040

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Gilead SciencesGS-4774
Precision BioSciencesPBGENE-HBV

Clinical Trials (2)

Total enrollment: 223 patients across 2 trials

NCT01943799Gilead SciencesGS-4774

Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B

Start: Sep 2013Est. completion: Mar 2015178 patients
Phase 2Completed
NCT07254208Precision BioSciencesPBGENE-HBV

A Long-term Observational Study in Participants Who Have Received PBGENE-HBV

Start: Dec 2025Est. completion: Jun 204045 patients
N/ANot Yet Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space